Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance
J. Clin. Invest. Zhiya Yu, et al. 114:551
doi:10.1172/JCI21695 [Go to this article.]

Problems with a PDF?